These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 36401355)

  • 21. HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin.
    Romani B; Kamali Jamil R; Hamidi-Fard M; Rahimi P; Momen SB; Aghasadeghi MR; Allahbakhshi E
    Sci Rep; 2016 Aug; 6():31924. PubMed ID: 27550312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early Infection.
    Rossenkhan R; MacLeod IJ; Brumme ZL; Magaret CA; Sebunya TK; Musonda R; Gashe BA; Edlefsen PT; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1031-1045. PubMed ID: 27349335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo.
    Sato K; Misawa N; Iwami S; Satou Y; Matsuoka M; Ishizaka Y; Ito M; Aihara K; An DS; Koyanagi Y
    PLoS Pathog; 2013; 9(12):e1003812. PubMed ID: 24339781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 Gag Recruits Oligomeric Vpr via Two Binding Sites in p6, but Both Mature p6 and Vpr Are Rapidly Lost upon Target Cell Entry.
    Wanaguru M; Bishop KN
    J Virol; 2021 Aug; 95(17):e0055421. PubMed ID: 34106747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virion-associated HIV-1 Vpr: variable amount in virus particles derived from cells upon virus infection or proviral DNA transfection.
    Singh SP; Tungaturthi P; Cartas M; Tomkowicz B; Rizvi TA; Khan SA; Kalyanaraman VS; Srinivasan A
    Virology; 2001 Apr; 283(1):78-83. PubMed ID: 11312664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vpr in plasma of HIV type 1-positive patients is correlated with the HIV type 1 RNA titers.
    Hoshino S; Sun B; Konishi M; Shimura M; Segawa T; Hagiwara Y; Koyanagi Y; Iwamoto A; Mimaya J; Terunuma H; Kano S; Ishizaka Y
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):391-7. PubMed ID: 17411372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.
    Paxton W; Connor RI; Landau NR
    J Virol; 1993 Dec; 67(12):7229-37. PubMed ID: 8230445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing.
    Forouzanfar F; Ali S; Wallet C; De Rovere M; Ducloy C; El Mekdad H; El Maassarani M; Aït-Ammar A; Van Assche J; Boutant E; Daouad F; Margottin-Goguet F; Moog C; Van Lint C; Schwartz C; Rohr O
    Sci Rep; 2019 Sep; 9(1):13154. PubMed ID: 31511615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of HIV-1 vpr product and function.
    Cohen EA; Terwilliger EF; Jalinoos Y; Proulx J; Sodroski JG; Haseltine WA
    J Acquir Immune Defic Syndr (1988); 1990; 3(1):11-8. PubMed ID: 2136707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vpr-host interactions during HIV-1 viral life cycle.
    Zhao RY; Li G; Bukrinsky MI
    J Neuroimmune Pharmacol; 2011 Jun; 6(2):216-29. PubMed ID: 21318276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus type 1 Vpr polymorphisms associated with progressor and nonprogressor individuals alter Vpr-associated functions.
    Hadi K; Walker LA; Guha D; Murali R; Watkins SC; Tarwater P; Srinivasan A; Ayyavoo V
    J Gen Virol; 2014 Mar; 95(Pt 3):700-711. PubMed ID: 24300552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative Temporal Viromics of an Inducible HIV-1 Model Yields Insight to Global Host Targets and Phospho-Dynamics Associated with Protein Vpr.
    Lapek JD; Lewinski MK; Wozniak JM; Guatelli J; Gonzalez DJ
    Mol Cell Proteomics; 2017 Aug; 16(8):1447-1461. PubMed ID: 28606917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral Therapy.
    Gill AJ; Kovacsics CE; Vance PJ; Collman RG; Kolson DL
    J Virol; 2015 Oct; 89(20):10656-67. PubMed ID: 26269184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variance in the HIV-1 founder virus Vpr affects its ability to induce cell cycle G₂arrest and cell apoptosis.
    Zhao JY; Ding JW; Mi ZY; Zhou JM; Wei T; Cen S
    Yi Chuan; 2015 May; 37(5):480-6. PubMed ID: 25998437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and functional characterization of human immunodeficiency virus type 1 VprC variants from north India: presence of unique recombinants with mosaic genomes from B, C and D subtypes within the open reading frame of Vpr.
    Bano AS; Sood V; Neogi U; Goel N; Kuttiat VS; Wanchu A; Banerjea AC
    J Gen Virol; 2009 Nov; 90(Pt 11):2768-2776. PubMed ID: 19605589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining the roles for Vpr in HIV-1-associated neuropathogenesis.
    James T; Nonnemacher MR; Wigdahl B; Krebs FC
    J Neurovirol; 2016 Aug; 22(4):403-15. PubMed ID: 27056720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence.
    Na H; Acharjee S; Jones G; Vivithanaporn P; Noorbakhsh F; McFarlane N; Maingat F; Ballanyi K; Pardo CA; Cohen EA; Power C
    Retrovirology; 2011 Jun; 8():44. PubMed ID: 21645334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 Vpr Reprograms CLR4
    Yan J; Shun MC; Hao C; Zhang Y; Qian J; Hrecka K; DeLucia M; Monnie C; Ahn J; Skowronski J
    mBio; 2018 Oct; 9(5):. PubMed ID: 30352932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 Vpr Induces Widespread Transcriptomic Changes in CD4
    Bauby H; Ward CC; Hugh-White R; Swanson CM; Schulz R; Goujon C; Malim MH
    mBio; 2021 Jun; 12(3):e0136921. PubMed ID: 34154423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low conservation of functional domains of HIV type 1 vif and vpr genes in infected mothers correlates with lack of vertical transmission.
    Yedavalli VR; Ahmad N
    AIDS Res Hum Retroviruses; 2001 Jul; 17(10):911-23. PubMed ID: 11461677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.